Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081.

Conrado Milani CoutinhoMeredith G WarshawGeraldo DuarteAlice StekAvy ViolariCristina B HoferJaime G DevilleJames Samwel NgochoJosé Henrique PilottoMario Dias CorreaDavid E ShapiroTrevon L FullerNahida ChakhtouraMark MirochnickEsaú C João

Published in: Journal of acquired immune deficiency syndromes (1999) (2022)

A raltegravir-based antiretroviral regimen was associated with significantly higher antepartum rate of weight gain and BMI increase compared with efavirenz-based treatment in antiretroviral-naive pregnant women.

Keyphrases

weight gain
hiv infected patients
hiv infected
antiretroviral therapy
pregnant women
body mass index
birth weight
human immunodeficiency virus
hiv positive
hiv aids
weight loss
physical activity
south africa
adipose tissue
smoking cessation
glycemic control